1. Home
  2. RPGL vs VIVS Comparison

RPGL vs VIVS Comparison

Compare RPGL & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Republic Power Group Limited Class A Ordinary Shares

RPGL

Republic Power Group Limited Class A Ordinary Shares

HOLD

Current Price

$2.05

Market Cap

2.3M

Sector

Technology

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$0.41

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPGL
VIVS
Founded
2015
2007
Country
Singapore
United States
Employees
8
9
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RPGL
VIVS
Price
$2.05
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
653.1K
4.5M
Earning Date
05-16-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
$21.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.43
52 Week High
$13.06
$5.30

Technical Indicators

Market Signals
Indicator
RPGL
VIVS
Relative Strength Index (RSI) 48.74 18.88
Support Level $1.90 N/A
Resistance Level $2.65 $2.21
Average True Range (ATR) 0.22 0.13
MACD 0.02 -0.03
Stochastic Oscillator 36.73 0.72

Price Performance

Historical Comparison
RPGL
VIVS

About RPGL Republic Power Group Limited Class A Ordinary Shares

Republic Power Group Ltd is a provider of customized ERP software solutions, consulting and technical support services, and peripheral hardware to corporate clients and government agencies, including airports, cruise terminals, and technology, trading, and logistics companies. The Company operates from Singapore and has historically served clients in Singapore and Malaysia, offering ERP systems with functions such as accounting, procurement, workflow automation, real-time monitoring, and capabilities including planning, surveillance, and threat detection. The Company leverages artificial intelligence and modular algorithms to address complex operational requirements and integrates sensors, controls, and other hardware to enable IoT connectivity with autonomous or semiautonomous outcomes.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: